TAKHZYRO (lanadelumab-flyo)
PLASMA KALLIKREIN INHIBITOR, RECOMBINANT MONOCLONAL ANTIBODY · PREVENTION OF ANGIOEDEMA ATTACKS IN PATIENT WITH HEREDITARY ANGIOEDEMA
DYAX CORP./SHIR